AGN and AGNPF Related Headlines
Go Back- Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa
- Algernon Health changes name to Grey Matters Health, implements 10:1 share consolidation
- Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation
- Algernon Health plans name change to Grey Matters Health, 10:1 share consolidation
- Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation
- Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers
- Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building
- Algernon Health raises $500,000 in private placement
- Algernon Health Announces Private Placement
- Algernon Pharmaceuticals changes name to Algernon Health
- Algernon Pharmaceuticals Completes Name Change to Algernon Health
- Catalyst MedTech Launches "Connect" Program to Expand Access to Advanced Imaging; Announces Initial Partnership with Algernon Pharmaceuticals
- Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection
- Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
- Algernon Pharmaceuticals changes name to Algernon Health
- Algernon Pharmaceuticals Announces Name Change to Algernon Health
- Algernon Announces Closing of the Private Placement Financing
- Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000
AGN and AGNPF Related Press Releases
Go Back- Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa
- Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation
- Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation
- Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers
- Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building
- Algernon Health Announces Private Placement
- Algernon Pharmaceuticals Completes Name Change to Algernon Health
- Catalyst MedTech Launches "Connect" Program to Expand Access to Advanced Imaging; Announces Initial Partnership with Algernon Pharmaceuticals
- Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection
- Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
- Algernon Pharmaceuticals Announces Name Change to Algernon Health
- Algernon Announces Closing of the Private Placement Financing
- Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000
